Torsten Zuberbier Selected Research

desloratadine (Aerius)

5/2013	Randomized controlled trial of desloratadine for persistent allergic rhinitis: correlations between symptom improvement and quality of life.
3/2013	Can on-demand non-sedating antihistamines improve urticaria symptoms? A double-blind, randomized, single-dose study.
1/2012	Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review.
1/2010	Efficacy of desloratadine in persistent allergic rhinitis - a GA²LEN study.
3/2009	High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Torsten Zuberbier Research Topics

Disease

40	Hypersensitivity (Allergy) 10/2022 - 02/2002
25	Asthma (Bronchial Asthma) 09/2022 - 01/2009
24	Urticaria (Hives) 01/2021 - 09/2002
17	Allergic Rhinitis 10/2022 - 09/2009
15	Chronic Urticaria 01/2020 - 02/2002
14	Atopic Dermatitis (Atopic Eczema) 01/2021 - 05/2005
11	COVID-19 03/2022 - 01/2020
11	Food Hypersensitivity (Food Allergy) 08/2021 - 09/2002
8	Anaphylaxis (Anaphylactic Shock) 09/2022 - 05/2014
7	Inflammation (Inflammations) 03/2021 - 02/2004
5	Rhinosinusitis 04/2022 - 09/2009
5	Skin Diseases (Skin Disease) 01/2022 - 07/2008
5	Angioedema 01/2020 - 01/2009
4	Infections 01/2021 - 06/2007
4	Rhinitis 11/2019 - 09/2009
4	Cold Urticaria 01/2018 - 09/2002
3	Seasonal Allergic Rhinitis (Hay Fever) 03/2022 - 04/2017
3	Hereditary Angioedemas 01/2020 - 04/2010
3	Neoplasms (Cancer) 11/2018 - 12/2011
3	Eczema 01/2017 - 01/2006
2	Respiratory Tract Diseases (Respiratory Tract Disease) 12/2021 - 09/2009
2	Nasal Polyps (Nasal Polyp) 01/2021 - 01/2020
2	Neurodermatitis (Lichen Simplex Chronicus) 01/2021 - 06/2016
2	Bacterial Infections (Bacterial Infection) 01/2021 - 01/2011
2	Pruritus (Itching) 01/2020 - 07/2011
2	Familial dermographism 01/2018 - 01/2011
2	Contact Dermatitis (Eczema, Contact) 10/2012 - 03/2007
2	type 2C Congenital disorder of glycosylation 09/2010 - 06/2005
2	Mastocytosis 10/2004 - 10/2003
1	Drug Hypersensitivity (Drug Allergy) 01/2022
1	Peanut Hypersensitivity (Peanut Allergy) 01/2021
1	Dysbiosis 01/2021
1	Cytokine Release Syndrome 12/2020
1	Insulin Resistance 12/2020
1	Lung Injury 12/2020
1	Wells syndrome 07/2020

Drug/Important Bio-Agent (IBA)

25	AllergensIBA 01/2022 - 01/2006
18	Immunoglobulin E (IgE)IBA 09/2022 - 09/2002
13	Histamine Antagonists (Antihistamines)IBA 07/2022 - 03/2009
8	Pharmaceutical PreparationsIBA 10/2022 - 10/2011
7	Omalizumab (Xolair)FDA Link 10/2018 - 01/2011
5	VaccinesIBA 01/2022 - 01/2016
5	CytokinesIBA 01/2022 - 02/2004
5	Histamine (Histamine Dihydrochloride)FDA Link 01/2021 - 01/2009
5	desloratadine (Aerius)FDA LinkGeneric 05/2013 - 03/2009
4	COVID-19 VaccinesIBA 01/2022 - 01/2021
4	Cholinergic Agents (Cholinergics)IBA 01/2020 - 02/2014
4	BradykininIBA 01/2020 - 04/2010
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2011 - 02/2004
3	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 01/2018
3	Interleukin-17 (Interleukin 17)IBA 08/2021 - 10/2016
3	Biological ProductsIBA 01/2021 - 10/2014
3	mepolizumabIBA 07/2020 - 10/2014
3	pimecrolimus (Elidel)FDA Link 07/2008 - 01/2007
2	AnkyrinsIBA 03/2022 - 01/2021
2	TabletsIBA 03/2022 - 01/2019
2	CurcuminIBA 03/2022 - 12/2020
2	AntioxidantsIBA 03/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2011
2	Monoclonal AntibodiesIBA 08/2021 - 01/2020
2	Interleukin-33IBA 03/2021 - 01/2020
2	Epinephrine (Adrenaline)FDA LinkGeneric 01/2021 - 01/2021
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 12/2013
2	bilastineIBA 01/2019 - 01/2012
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 01/2018
2	Rituximab (Mabthera)FDA Link 08/2017 - 10/2014
2	Chymases (Chymase)IBA 02/2017 - 09/2010
2	Tryptases (Tryptase)IBA 02/2017 - 09/2010
2	Food Additives (Food Additive)IBA 06/2016 - 02/2002
2	Interleukin-6 (Interleukin 6)IBA 12/2011 - 02/2004
2	Interleukin-8 (Interleukin 8)IBA 12/2011 - 02/2004
2	anti-IgE antibodiesIBA 07/2011 - 07/2007
2	SteroidsIBA 01/2010 - 01/2007
1	azelastine (Optivar)FDA LinkGeneric 10/2022
1	Fluticasone (Cutivate)FDA LinkGeneric 10/2022
1	ChemokinesIBA 04/2022
1	vanillinIBA 03/2022
1	Transcription Factors (Transcription Factor)IBA 03/2022
1	mRNA VaccinesIBA 01/2022
1	Interleukin-17 ReceptorsIBA 08/2021
1	BNT162 VaccineIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	PrebioticsIBA 01/2021
1	glucoraphaninIBA 01/2021
1	Nasal Decongestants (Decongestants)IBA 01/2021
1	sulforaphaneIBA 12/2020
1	BerberineIBA 12/2020
1	GenisteinIBA 12/2020
1	ResveratrolIBA 12/2020
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 12/2020
1	QuercetinIBA 12/2020

Therapy/Procedure

18	Therapeutics 01/2021 - 10/2004
11	Immunotherapy 01/2020 - 11/2009
6	Drug Therapy (Chemotherapy) 10/2022 - 11/2012
3	Injections 01/2022 - 06/2007
2	Gluten-Free Diet 01/2018 - 01/2017
1	Emergency Treatment 01/2021
1	Biological Therapy 01/2021